Documenti analoghi

• Managing Delayed or Missed Doses of Prolonged‐Release Tacrolimus in Transplant Recipients: Implications for Drug Exposure and Recovery Strategies
  di: S. Arraki Zava, et al.
  Pubblicazione: (2025)
• The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of mitiperstat
  di: Chandrali S. Bhattacharya, et al.
  Pubblicazione: (2024)
• Fixed drug eruption induced by mycophenolate mofetil, a rare entity with significant consequences
  di: Camille Kieffer, et al.
  Pubblicazione: (2026)
• Population pharmacokinetics and bioavailability of tacrolimus oral suspension in children with haematopoietic stem cell transplant
  di: Lucas Brstilo, et al.
  Pubblicazione: (2025)
• To be or not to be, when synthetic data meet clinical pharmacology: A focused study on pharmacogenetics
  di: Jean‐Baptiste Woillard, et al.
  Pubblicazione: (2024)